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Women’s use of Preventive Primary Care in the Late Postpartum Period 
Katie Price B.S., Martha Seagrave BSN, PA-C 







The literature has limited data on how women access health care after the traditional postpartum 
period (<60 days postpartum). Modeled after a paper by Bryant (2016), this project assesses the 
prevalence of primary care visits in the late postpartum period (LPP)(60- 730 days postpartum). 
Study objectives included (1) Identify demographics of general delivering population at UVMMC 
compared to patients with UVM-affiliated primary care provider (UVMPCP). (2) Understand how the 
general delivering population uses the UVMHN LPP (3) Among women with a UVM-affiliated PCP, 
identify the prevalence of preventive care visits in the LPP. (4) Identify characteristics associated 
with LPP visit attendance. Hypothesis: Women with an established PCP prior to pregnancy are more 
likely to attend preventive PCP LPP visits. This was a retrospective cohort study for all women who 
delivered at UVMMC between 7/1/2015-6/30/2017. Data was extracted from Epic EMR. During the 
study period, 4169 women had one singleton pregnancy, 3413 (82%) had a known PCP, and 1279 
(31%) had UVMPCP. 2535 (61%) of all delivering singleton women and 1112 (87%) of UVMPCP 
women had at least one clinical visit within UVMHN in the LPP. 959 (75%) of UVMPCP women had a 
LPP PCP visit, and 382 patients (30%) had preventative PCP LPP visits. Our hypothesis was rejected 
(OR 0.930), but attending any LPP PCP visit was associated with having a PCP established prior to 
pregnancy (OR 1.684). Attending preventive PCP visit was associated with having the same 
delivering provider as PCP (OR 1.742), a pre-pregnancy PCP visit (OR 1.460), a PCP visit during 
prenatal time (OR 1.459), ED visit early postpartum period (OR 0.402), a fetal or neonatal demise 
(OR 0.445), being single (0.601), and with public insurance (OR 0.489). Further work in 
understanding these associations will be important in developing improved transition of care 
models and increasing overall engagement in women’s preventive medicine. 
Introduction 
Maternal child health and women’s health practice and policy is shifting towards more holistic and 
lifelong approach in the wake of increasing prevalence of chronic disease in childbearing aged women. 
(1). In this model, recognizing that pregnancy is a ‘window of opportunity’ (1) to engage women in 
primary and preventive care is essential. In the United States, 58.9% of pregnancies are unplanned (2). 
The high frequency of care contact in pregnancy is an opportunity to diagnose chronic disease, manage 
behavior risk factors, and initiate therapy. Continuing to address these problems after this structured 
period, remains a challenge with a fragmented transition of care process from obstetrical care into well 
woman health.  
In the US, increasing rates of maternal morbidity and mortality have driven significant ongoing efforts to 
increase participation in the postpartum visit (3, 1, 4, 5) and identifying models of care that best address 
new mothers’ needs (6, 7, 8). Postpartum care has been traditionally defined as the 6-8wks after 
delivering by the medical community; however, mothers continue to experience change in physical and 
mental well-being over the year and beyond after delivery (9, 10, 11).  
Multiple studies have identified gaps mothers experience in their own postpartum care and reasons for 
postpartum visit non-attendance(7,4,5). The psychosocial context of motherhood has been identified as 
a critical yet, infrequently addressed area of need for new mothers (8). Using the postpartum visit to 
assess concerns beyond the physiologic and connecting women with professional and social supports in 
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this critical time should be a priority. Essential to this transition is continued access to maternal health 
care into early motherhood and beyond.  
Work on optimizing transition of care from postpartum to well-woman care/interpregnancy care is 
lacking. Most new mothers interact with a minimum of three distinct health care providers after 
pregnancy: obstetrician-gynecologist, primary care physician, and pediatrician. This “siloed” system 
provides a challenge in communicating health needs and engaging patients in care beyond the 
postpartum period (12). The ACOG interpregnancy consensus statement (13) acknowledges need for 
continued care, and it recommends discussing a preferred primary care provider during the postpartum 
period. However, there is limited data on how this process is integrated into practice and the prevalence 
of well women visit attendance in the late postpartum period (beyond 2 months).  
Bryant et al (12) began to address this gap in the literature by evaluating visit patterns among women 
who had an established primary care prior to pregnancy in an academic medical center. Their data 
demonstrate high prevalence of primary care visits (80.7% of patients) during the 2 years postpartum. 
Their paper is presented as part of a larger project to “think more expansively about health care 
delivered at the conclusion of a pregnancy and in the years beyond..”(12) Apart from this more 
comprehensive data set, a few studies have looked at visit patterns in specific patient populations with 
medical comorbidities including diabetes and hypertension (14, 15, 16, 17). 
In this study we build upon Bryant et al. (2016)’s work and aim to map out current patterns of how 
women in Vermont interact with the UVM health network (UVMHN) in the late postpartum period 
(defined as 60-730 days after delivery). We included all women who delivered at UVM from 2015-2017 
regardless of where they received prenatal care and affiliation of primary care physician. We were 
specifically interested in identifying women who had a documented primary care visit in the 12 months 
prior to conception and how they access preventive medical care in the late postpartum period. This 
project will provide context for whom these patients are among the general delivering population at an 
academic medical center. It will also add to the limited literature on health behavior in this period, 
describing a more rural-suburban population. Our study objectives are as follows: 
1. Identify demographics of general delivering population at UVMMC and compare to that of 
patients with UVM-affiliated primary care provider 
2. Understand how the general delivering population uses the UVMHN in the late postpartum 
period (60-730 days after birth) 
3. Among women with a UVM-affiliated PCP, identify the prevalence of preventive care visits in the 
late postpartum period (LPP) 
4. Identify patient characteristics associated with LPP visit attendance 
Hypothesis: Women with an established PCP prior to pregnancy are more likely to attend preventive 
PCP visit in the LPP 
Methods 
We designed a retrospective cohort study that included all women who delivered at UVMMC between 
July 1, 2015- June 30, 2017. Patient data extracted from EMR encompassed any encounters in the 12 
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months prior to pregnancy through 730 days after delivery. Women who had multiple pregnancies in 
the study period or gave birth to multiples were excluded.  
To complete objective 1, the following information was extracted from Epic EMR to understand the 
characteristics of the delivering population at UVMMC: 
• Demographics: Maternal age, race, marital status, insurance type, radius of residence from 
hospital (by zip code), and parity. (Table 1) 
• Clinical characteristics: BMI recorded at first prenatal visit, gestational age at delivery, mode of 
delivery, delivery outcome, chronic medical comorbidities, obstetrical conditions in current 
pregnancy, known primary care provider, and type of prenatal provider (Table 1) 
• Visit attendance in the EPP (<60 days after delivery): postpartum visit, obstetrical visit, PCP visit, 
emergency or urgent care visit, inpatient admission, non-PCP outpatient visit. (Table 2) 
Chi-square analysis was performed comparing the UVM-PCP population to the general delivering 
population. Post-hoc testing was conducted for significant findings.  




Patient zipcodes were transposed into radii using 
https://www.freemaptools.com/find-zip-codes-inside-radius.htm 
Radii include: <25 miles, 25-50miles, 50-100miles, 100-150miles, >150miles 
Gestational Age 
at delivery 




ICD10 diagnostic codes for diabetes mellitus, hypertension, hyperthyroidism, 
hypothyroidism, asthma, bipolar disorder, depression, anxiety, breast cancer, 
cardiovascular disease, cervical cancer, chronic kidney disease, Factor V Leiden, HIV, 





ICD10 diagnostic codes for gestational diabetes, pre-eclampsia, hypertension in 
pregnancy, puerperal infection, antepartum hemorrhage, postpartum hemorrhage, 
Rh isoimmunization, uterine rupture, pregnancy thromboembolism, fetomaternal 
placental transfusion syndrome, fetal abnormality 
Prenatal Provider 
General: Private practice, community health center, UVM-affiliated 
UVM subpractices: REI, MFM, UOM (general OB), Family Medicine, CNM 
 
To complete objective 2, visit attendance was extracted for patients in the late postpartum period (LPP) 
(60-730 days after delivery) for the following types of visits: PCP visit, preventive PCP visit, ED visit, IP 
visit, non-PCP visit. (Table 2)  
Table 2 Visit Definitions 
Visit Definition 
Prenatal Visit 
Visit with statistical code Z9902 or Encounter type of 'ANTEPARTUM VISIT', within the 




A visit to any Family Medicine or Internal Medicine outpatient Department at 
UVMMC. Excluding prenatal and postpartum visits 
PCP Preventive 
Care Visit 
A visit to any Family Medicine or Internal Medicine outpatient Department at 
UVMMC using CPT code 99381-99397 or 99401-99409 
Postpartum Visit Visit with statistical code Z9924, after delivery. 
OB Visit Visit to a OB or OB/GYN department  
ED Visit  Visit to ED or urgent care where patient was discharge from ED (not admitted) 
Inpatient Visit 
 Visit where patient was admitted as an inpatient. (If admitted through ED, ED visit 
not counted) 
Non-PCP Visit 
Any other visit that is not a nurse visit, lab draw, imaging, or any of the other 
categories described above. Hospital outpatient procedures/observation visits are 
included in this bucket. 
 
To complete objective 3, the following PCP characteristics, visit attendance, and visit timing were 
extracted for patients with an identified UVM-affiliated PCP: 
• PCP characteristics: Time PCP established in relation to first PN visit (before, same date, after), 
PCP= delivering provider (Prenatal practice was the same as PCP) 
• Visits: PCP visit in the 12 months prior to pregnancy, PCP visit during prenatal time (excluding 
prenatal visits), preventive PCP visit prior to delivery date, PCP visit EPP, PCP visit LPP, 
preventive PCP visit LPP 
To complete objective 4, all patients with UVM-PCP bivariate analyses were performed with LPP visit 
attendance type and (1) sociodemographics, (2) clinical characteristics, (3) EPP visit attendance. Chi-
square with P<0.05 was calculated in SPSS as well as unadjusted odds ratios with 95% CI. This analysis 
evaluated the study hypothesis.  
Results 
Between July 1, 2015 and June 30, 2017, 4377 women delivered at UVMMC. Of these women, 4169 had 
one, singleton pregnancy and within this population, 1279 had a UVM-affiliated PCP. These women 
were the primary study population. Table 3 describes the general delivering population including 
women with multiple pregnancy and those with multiples.  
Table 3 Delivering Population Characteristics 
 
All Women Women with 
UVM PCP  
n n 
Total Women 4377 1333 
Women who had one, singleton pregnancy in study period* 4169 1279 
Women who had multiple pregnancies in study period 81 21 
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Women who had one pregnancy with multiples 121 30 
Women who had multiple pregnancies, one of which had multiples 6 3 
Women with one singleton pregnancy AND a documented new 
prenatal visit 
305 99 
*Primary study population    
 
Tables 4, 5, and 6 include patient demographics, clinical characteristics, and EPP visit attendance. Among 
all singleton women, most were between 30-39 years old, parity 0, had at least one chronic medical 
comorbidity, an identified PCP within the EMR, private insurance, lived within 25 miles of UVMMC, 
white, and married. In the study pregnancy, most women were healthy weight with first prenatal BMI 
18-24, did not have an obstetrical condition in current pregnancy, delivered at term (<37wks), via 
spontaneous vaginal delivery, an alive newborn, used a UVM-affiliated prenatal provider and CNM most 
among UVM sub-practices. Most women attended a scheduled postpartum visit and had an additional 
obstetrical visit in the early postpartum period.  
Compared to all singleton mothers, women with a UVM PCP were noted to be more likely older, have 
private health insurance, live closer to the hospital, be married, deliver at term, and have a family 
medicine prenatal provider. They were less likely to use the community health center for prenatal care 
or have MFM as a prenatal provider.  There was no noted difference in the attendance of EEP visits.  





UVM PCP Chi Square 
 n % n % (adjusted  P value) 
Demographics      
Age     0.002 
<20 years 98 2.4% 13 1.0% (0.009) 
20-29 years 1578 37.9% 425 33.2% (0.014) 
30-39 years 2332 55.9% 797 62.3% (0.001) 
>/= 40 years 160 3.8% 44 3.4% (0.596) 
      
Parity     0.563 
0 1807 43.3% 555 43.4%  
1 401 9.6% 122 9.5%  
2 1185 28.4% 388 30.3%  
>2 776 18.6% 214 16.7%  
      
Public insurance 1320 31.7% 324 25.3% 4.890E-04 
      
Radius from Hospital     1.572E-19 
<25 miles 3325 79.8% 1183 92.5% (0) 
20-50 miles 604 14.5% 85 6.6% (0) 
7 
Price 
50-100 miles 156 3.7% 2 0.2% (0) 
100-15 miles 11 0.3% 0 0.0% (0.082) 
>150 miles 27 0.6% 8 0.6% (0.984) 
Unknown 46 1.1% 1 0.1%  
      
Race     0.347 
White 3567 85.6% 1151 90.0%  
Asian 202 4.8% 44 3.4%  
Black 146 3.5% 32 2.5%  
Declined 54 1.3% 17 1.3%  
Hawaiian-Pacific 6 0.1% 2 0.2%  
Native American 21 0.5% 3 0.2%  
Multiracial 61 1.5% 19 1.5%  
Other 8 0.2% 1 0.1%  
Marital Status      4.970E-04 
Single 1215 29.1% 298 23.3%  
Married 2778 66.6% 934 73.0%  
 
 
Table 5 Clinical Characteristics 
 All Singleton Mothers Women with UVM PCP Chi Square 
 n % n % (adjusted P) 
Clinical Characteristics      
Gestational Age at Delivery     0.002 
<24w 18 0.4% 2 0.2% (0.159) 
24-31w 6d 66 1.6% 8 0.6% (0.023) 
32-36w 6d 314 7.5% 63 0.6% (0.008) 
>37w 3657 87.7% 1164 91.0% (0.000) 
Unknown 114 2.7% 42 3.3%  
Mode of Delivery     0.283 
SVD 2806 67.3% 882 69.0%  
CS LST 1037 24.9% 309 24.2%  
CS Classical 17 0.4% 1 0.1%  
CS low vertical 10 0.2% 2 0.2%  
Operative Vaginal 217 5.2% 67 5.2%  
Breech Vaginal 11 0.3% 0 0.0%  
Unknown 71 1.7% 18 1.4%  
Delivery Outcome     0.044 
Alive 4011 96.2% 1230 96.2% (0.020) 
Fetal Demise 26 0.6% 3 0.2% (0.134) 
Neonatal Demise 12 0.3% 0 0.0% (0.047) 
Unknown 120 2.9% 46 3.6%  
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BMI at First Prenatal Visit     0.352 
<18 8 0.2% 0 0.0%  
18-24 846 20.3% 309 24.2%  
25-29 517 12.4% 156 12.2%  
30-34 292 7.0% 98 7.7%  
>35 344 8.3% 107 8.4%  
unknown 2162 51.9% 609 47.6%  
Chronic Medical 
Comorbidities 2478 59.4% 763 59.7% 0.923 
Obstetrical Condition in 
current pregnancy 1397 33.5% 408 31.9% 0.376 
Identified PCP in Epic 3413 81.9% 1279 100% N/A 
 
Table 6 Prenatal Provider Type and EPP visits 
 All Singleton Mothers Women with UVM PCP Chi Square 
 n % n % (adjusted P) 
Prenatal Provider Type     9.100E-05 
Private Practice 1600 38.4% 520 40.7% (0.289) 
Community Health Center 110 2.6% 7 0.5% (0.000) 
UVM-Affiliated 1909 45.8% 593 46.4% (0.920) 
UVM Subpractice     1.424E-10 
REI 9 0.2% 2 0.2% (0.646) 
MFM 524 12.6% 98 7.7% (0.000) 
UOM 454 10.9% 139 10.9% (0.912) 
Family Medicine 141 3.4% 120 9.4% (0) 
CNM 781 18.7% 234 18.3% (0.603) 
Early Postpartum Period visits (<60 days from delivery) 
Postpartum visit*  1213 56.11% 414 68.0%  
OB visit* 1300 60.13% 406 66.7%  
PCP visit   268 21.0% N/A 
Non-PCP OP visit 786 18.9% 258 20.2% 0.396 
ED visit 234 5.6% 89 7.0% 0.166 
Inpatient Admission 43 1.0% 15 1.2% 0.71 
* These analyses are limited to women with a UVM-affiliated PN provider 
 
Looking at visit attendance in the late postpartum period (LPP), the majority of singleton mothers had at 
least one documented visit (Table 7). On average, each patient had 5.70 visits; however, the range is 




Table 7 LPP visit attendance 
 
All Singleton Mothers Women with UVM PCP 
 
n % mean visits 
±SD (min,max) 
n % mean visits 
±SD (min,max) 
Any LPP Visit  2535 60.8% 5.70±7.23 (1,92) 1112 86.9% 7.57±10.14 (1,92) 
nonPCP LPP 1510 36.2% 4.40±7.24 (1,74) 581 45.4% 5.12±8.31(1,74) 
ED LPP 1150 27.6% 2.02±2.10 (1,34) 429 33.5% 2.01±2.36 (1,34) 
IP LPP 352 8.4% 1.13±0.65 (1,10) 105 8.2% 1.08±0.36 (1,4) 
No documented LPP visits 1634 39.2% N/A 167 13.1% N/A 
PCP LPP 
   
959 75.0% 4.68± 5.42 (1,58) 
PrevPCP LPP 
   
382 29.9% 1±0 (1,1) 
 
Among women with a UVM-affiliated PCP with known established date, 76.8% had an established 
provider before the pregnancy, and 62.6% of patients attended a visit in the 12 months prior to 
pregnancy. 10.5% of patients had the same delivering provider as PCP (Table 8).  
Table 8 PCP characteristics and interactions 
 UVM PCP Characteristics Mean visits per patient  
 n % ± SD (min, max) 
PCP established before prenatal course 459 76.76%  
PCP established after prenatal course 132 16.10%  
PCP established on prenatal course day 0 7 0.85%  
PCP established date unknown 681 53.24%  
     
PCP= delivering provider 134 10.48%  
     
PCP visit prior to pregnancy 800 62.55% 2.63± 2.07 (1,17) 
PCP visit during prenatal time* 605 47.30% 4.14± 4.72 (1, 21) 
PCP EPP visit 268 21.0% 1.38± 0.95 (1, 10) 
Preventive visit PCP LPP 382 29.9% 1± 0 (1,1) 
PCP visit LPP 959 75.0% 4.66± 5.41 (1,58) 
*Excludes regularly scheduled PN visits    
    
 
Figure 1 displays visit timing for each type of primary care visit. In general, there was not trend to timing 
of visits, except more PCP visits during the prenatal time which occurred in the beginning of this period. 
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Figure 1 PCP visit timing distribution 
 
Bivariate analyses were performed for women with UVM PCP and specific LPP visit attendance (Tables 9, 
10, 11). 
Any LPP 
Demographics and any LPP visit attendance was notable for decreased attendance in patients living 
outside 25 mile radius of the hospital (OR 0.404). Clinical characteristics and any LPP visit attendance 
was decreased in patients with a private prenatal provider (OR 0.686) and increased in women with a 
family medicine prenatal provider (OR 5.434). PCP characteristics and EPP attendance was notable for 
increased LPP attendance with PCP= delivering provider office (OR 4.252), PCP established before 
pregnancy (OR 2.068), attended a PCP visit pre-pregnancy (OR 3.011), attended PCP visit during prenatal 
period (OR 3.363), and attended a PCP EPP visit (OR 5.098).  
PCP LPP 
Demographics and PCP LPP visit was notable for decreased attendance in mothers parity >P2 (OR 0.700), 
having public insurance (OR 0.744), living outside 25 mile radius of the hospital (OR 0.569), black women 
(OR 0.274), being single (OR 0.682). Clinical characteristics and PCP LPP visit attendance was increased in 
patients with operative vaginal delivery (OR 2.103), family medicine prenatal provider (OR 8.039), and 
decreased in patients with CHC as prenatal provider (OR 0.215). PCP characteristics and EPP visits with 
PCP LPP visit attendance was increased in patients with PCP=delivering provider (OR 3.741), PCP 
established before prenatal course (1.684), Pre-pregnancy PCP visit (OR 4.367), PCP visit during prenatal 
period (3.741), EPP PCP visit (OR 8.561).  
Preventive PCP LPP 
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Demographics and preventive PCP LPP visit was notable for increased attendance in mothers 30-39 
years old (OR 1.365), and decreased attendance with public insurance (OR 0.489), being single (OR 
0.601). Clinical characteristics and preventive PCP LPP visit attendance was decreased in patients with a 
fetal or neonatal demise (OR 0.445). PCP characteristics and EPP visit attendance and Preventive PCP 
visit attendance was increased in patients with PCP=delivering provider (OR 1.742), PCP established 
before pregnancy (OR 1.460), PCP visit during prenatal period (OR 1.459), and decreased attendance 
with EPP ED visit (0.402).  
Our hypothesis was rejected with an OR 0.930 for patients with an established PCP before prenatal 
course and attending a preventive PCP visit in the LPP 
Non-PCP LPP 
Demographics and other non-PCP outpatient LPP visit attendance was increased with public insurance 
(OR 1.377), decreased attendance with zip >25miles (OR 0.617). Clinical characteristics and Non-PCP 
outpatient LPP visit attendance did not have any associations. Bivariate analysis of PCP characteristics 
and EPP visits with Non-PCP LPP visit attendance was increased in patients with Pre-pregnancy PCP visit 
(OR 1.573), PCP visit during prenatal period (OR 1.528), ED EPP (OR 1.701), PCP EPP (OR 1.698), non-PCP 
EPP (OR 1.423).  
ED LPP 
Demographics and emergency LPP visits was notable for increased attendance in patients less than 20 
years old (OR 4.494), with public insurance (2.585), black women (OR 2.598), being single (OR 2.795), 
and decreased with zip >25 miles (0.348). Clinical characteristics and emergency LPP visit noted 
attendance increased in patients with a cesarean section (OR 1.544), patients with BMI 30-34 (OR 
1.828), and BMI >35 (2.113), and decreased in patients with private prenatal provider (OR 0.687). PCP 
characteristics and EPP visits with ED LPP visit noted attendance was increased in patients with PCP visit 
during prenatal time (OR 1.331), ED EPP visit (OR 3.127), EPP PCP (OR 1.380), EPP non-PCP (OR 1.335).  
Inpatient Admission LPP 
Demographics and inpatient admission was notable for decreased occurrence age 30-39 years old (OR 
0.060), Parity P1 (OR 0.487) and increased in patients with public insurance (OR 1.699). Clinical 
characteristics and inpatient admission noted decreased occurrence in patients with pre-pregnancy BMI 





Table 9 Bivariate Analysis for demographics and LPP visits for women with UVM-affiliated PCP 
DEMOGRAPHICS ANY LPP PCP LPP 




Emergency or Urgent 
Care LPP 
Inpatient Admission  
LPP 
 OR CI OR CI OR CI OR CI OR CI OR CI 
AGE (REF 20-29) NS  NS    NS      
<20     
0.203 
(0.026, 1.564) NS   
4.494 




20-29            
 
30-39     
1.365 




>40     
1.378 




             
PARITY (REF P0) NS    NS  NS     
 
Parity 0            
 
Parity 1   
1.001 
(0.632, 1.586) NS     
0.707 




Parity 2   
0.990 






Parity >2   
0.700 
(0.483, 0.993) 95%     
1.331 




             
INSURANCE TYPE (REF 
PRIVATE) NS           
 
Private insurance            
 
Public   
0.744 
(0.561, 0.986) 95% 
0.489 
(0.361, 0.644) 95% 
1.377 
(1.070, 1.773) 95% 
2.585 




ZIP RADIUS FROM 
UVMMC) (REF < 25 miles)           NS 
 
Zip 25            
 
Zip >25 mi 
0.404 
(0.246, 0.662) 95% 
0.569 
(0.367, 0.884) 95% 
1.121 
(1.001, 1.256) P<0.10 
0.617 
(0.398, 0.955) 95% 
0.348 
(0.198, 0.612) 95%  
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DEMOGRAPHICS ANY LPP PCP LPP 




Emergency or Urgent 
Care LPP 
Inpatient Admission  
LPP 
 OR CI OR CI OR CI OR CI OR CI OR CI 
RACE (REF WHITE) NS    NS  NS    NS 
 
White            
 
Nonwhite   
0.538 
(0.351, 0.824) 95%     
1.381 
(0.911, 2.093) NS  
 
Asian   
0.829 
(0.421, 1.632) NS     
0.848 
(0.438, 1.638) NS  
 
Black   
0.274 
(0.135, 0.557) 95%     
2.598 
(1.279, 5.281) 95%  
 
Hawaiian-Pacific Islander   
0.311 
(0.019, 4.988) NS     
6.055 
(0.628, 58.403) NS  
 
Native American   
0.622 
(0.056, 6.884) NS     
1.010 
(0.091, 11.179) NS  
 
Multiracial   
0.674 
(0.254, 1.789) NS     
1.179 
(0.460, 3.019) NS  
 
             
MARITAL STATUS (REF 
MARRIED) NS      NS    NS 
 
Single   
0.682 
(0.511, 0.910) 95% 
0.601 
(0.443, 0.816) 95%   
2.795 
(2.136, 3.657) 95%  
 






Table 10 Bivariate analysis clinical characteristics and LPP visits among women with UVM-affiliated PCP 
CLINICAL CHARACTERISTICS ANY LPP PCP LPP 








 OR CI OR CI OR CI OR CI OR CI OR CI 
GESTATIONAL AGE  
(REF >37wk) NS  NS  NS  NS  NS    
GA <24wk 
          
11.933  
(0.740, 192.38) NS 
GA 24-31w6d 
          
1.705  
(0.207, 14.009) NS 
GA 32-36w6d 
          
1.989  
(0.951, 4.159) P<0.10 
GA >37              
            
MODE OF DELIVERY  
(REF SVD) NS    NS  NS    NS  




(0.641, 1.148) NS 
0.991  
(0.676, 1.453) NS   
1.544  




(1.025, 4.315) 95% 
1.524  
(0.644, 3.607) NS   
1.160  
(0.687, 1.959) NS    
            
DELIVERY OUTCOME  
(REF ALIVE) NS  NS    NS  NS  NS  
Alive             
Demise (Fetal or neonatal) 
    
0.445  
(0.227, 0.871) 95%        
            
BMI AT FIRST PRENATAL 
VISIT (REF 18-24) NS  NS  NS  NS      
BMI 18-24             
BMI 25-29 
        
1.382  
(0.926, 2.065) NS 
0.407  
(0.175, 0.944) 95% 
BMI 30-34 
        
1.828  
(1.149, 2.907) 95% 
0.368  
(0.127, 1.069) P<0.10 
BMI >35 
        
2.113  
(1.350, 3.309) 95% 
0.795  
(0.366, 1.725) NS 
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CLINICAL CHARACTERISTICS ANY LPP PCP LPP 








 OR CI OR CI OR CI OR CI OR CI OR CI 
Chronic Medical 
Comorbidities NS  NS  NS  NS  NS  NS   
            
OB condition in current 
Pregnancy NS  NS  NS  NS  NS  NS   
            
PN PROVIDER TYPE  
(REF UVM)     NS  NS    NS  
Private 0.686  
(0.481, 0.977) 95% 
0.777  
(0.591, 1.022) P<0.10     
0.687  
(0.524, 0.885) 95%   
CHC 0.302  
(0.057, 1.591) NS 
0.215  
(0.047, 0.972) 95%     
0.678  
(0.130, 3.525) NS   
UVM             
UVM PROVIDER SUBTYPE 
(REF UOM)       NS  NS  NS  
MFM 0.771  
(0.365, 1.629) NS 
0.721 
 (0.409, 1.272) NS 
0.685  
(0.380, 1.235) NS       
UOM (general UVM OB)             
Family Medicine 5.434  
(1.552, 19.031) 95% 
8.039  
(3.040, 21.258) 95% 
1.595  
(0.957, 2.658) P<0.10       
CNM 0.985  
(0.520, 1.867) NS 
1.061  
(0.655, 1.717) NS 
0.823  





Table 11 bivariate analysis of PCP characteristics and EPP visits with LPP visits among women with UVM-affiliated PCP 
 ANY LPP PCP LPP 








 OR CI OR CI OR CI OR CI OR CI OR CI 




(1.714, 10.549) 95% 
3.741  
(2.038, 6.866) 95% 
1.742  










before PN course 
2.068  
(1.214, 3.524) 95% 
1.684  
(1.106, 2.566) 95% 
0.930  









Pre-preg PCP visit 
3.011  
(2.154, 4.208) 95% 
4.367  
(3.342, 5.706) 95% 
1.460  









PCP visit during PN 
time 
3.363  
(2.319, 4.875) 95% 
3.741  
(2.823, 4.957) 95% 
1.459  









             
EPP VISITS             
EPP ED  NS  NS 
0.402  





(1.943, 5.032) 95%  NS 
EPP IP  NS  NS  NS  NS  NS  NS 
EPP PCP 
5.098  










(1.031, 1.848) 95%  NS 
EPP Non-PCP OP  NS  NS 
0.833  












In this study we have summarized health visit patterns in the late postpartum period for women who 
had one, singleton pregnancy. Women with a UVM-affiliated PCP were evaluated for their interactions 
with PCP services in the twelve months prior to pregnancy through 730 days after delivery. In 
comparison to the general ‘singleton mothers’ population, these women had markers of lower risk 
pregnancy (delivered >37wks, fewer had MFM as a prenatal provider). They were also older, had private 
health insurance, lived closer to the hospital, and married. Understanding the visit patterns in these 
women with established primary care will help relate future work on identifying characteristics of 
women who have not reconnected with the system after pregnancy.  
In comparison to Bryant’s LPP visit findings, the prevalence of non-PCP types of LPP visits for our 
UVMPCP population were different(our study, Bryant’s): ED LPP (33.5%, 13.9%), other non-PCP (45.4%, 
72.6%), inpatient admission (8.4%, 3.0%) (12). These differences may require further investigation but 
may be attributed due to geographic location, including fewer specialty services. The general singleton 
population in our study had an overall decreased prevalence of LPP visits (60.8%) which may be 
accounted for by increased distance from UVMMC or use of providers outside UVM network. 
Our findings on PCP service interactions are consistent with other data. In our study, 62.5% of patients 
had a PCP visit in the 12 months prior to pregnancy. The national PRAMS survey in 2017 (2) reported 
67.7% of women reported having a health care visit in the 12 months prior to pregnancy. These data 
appear similar, but it is important to note that the PRAMS survey does not specify type of healthcare 
visit. Our EPP (21.0%) and LPP (75%) PCP visit attendance was similar to Bryant’s findings (14.4%, 
80.7%). Our data points around PCP visits in prenatal course (distinct from prenatal visits) and 
preventive visits in the LPP are unique data points, which may encourage further work on the 
interaction between primary care and obstetrical care services during and after pregnancy. Preventive 
PCP LPP visits prevalence was much lower (29.9%) which suggests it is important for PCPs to do regular 
preventive health screenings at any visit. In addition, the association between operative vaginal delivery 
(OR 2.103) and EPP PCP visits may be reflective of gap in care between services and patient expectations 
about symptoms, similar to findings in Martin 2014 (7).  
While our hypothesis of having an established PCP prior to pregnancy would be associated with an 
increased likelihood of having a preventive PCP visit LPP was rejected, it was seen in any PCP LPP visit 
attendance (OR 1.684). In addition, multiple other factors were associated with preventive PCP LPP 
visits. Positive factors including having the same delivering provider as PCP (OR 1.742), a pre-pregnancy 
PCP visit (OR 1.460), a PCP visit during prenatal time (OR 1.459). Negative factors included a 
documented ED EPP visit (OR 0.402), a fetal or neonatal demise (OR 0.445), being single (0.601), and 
with public health insurance (OR 0.489). These relationships will require a further multivariable analysis 
to control for confounding variables, but they may help identify women who are at risk in the immediate 
and EPP of not re-engaging with care.  
The data in this study and Bryant’s is important to help inform strategies to improving access and 
utilization of primary care and preventive care services in the months to years after delivery. Capitalizing 
on the regular frequency of well child visits in the first two years, Centering Parenting is one model that 
is integrating postpartum and well child visits(18, 19). Additional work has been done on openness to 
parents and pediatricians on individual contraceptive counseling during well child visits (20, 21). While 
these models focus primarily on maternal health in the EPP, routine screening of parental primary care 
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access at well child visits could be incorporated into social determinants of health assessments. The 
medical home is another model that decreases geographic barriers to care if both pediatric and well 
woman health can occur at the same site. In our study, women with family medicine prenatal providers 
were significantly more likely to engage in PCP LPP care (OR 8.039), and often family medicine providers 
practice within an integrated medical home.  
This study adds to the limited pool on health visit pattern data in the months to years after pregnancy. It 
has begun to delineate some associations with increased engagement in primary care services and 
preventive medicine among patients. To strengthen the findings in this report, a multivariable analysis 
should be completed to control for confounding variables. Additional beneficial analyses that should be 
done with this dataset include understanding clinical characteristics and demographics of patients who 
do not have a designated PCP in the EMR and those who did not attend a LPP visit. These are patients 
who may be at increased risk for increased utilization of emergency services for health. Also, further 
investigation into specific medical comorbidities or obstetrical comorbidities and visit attendance would 
be important. This data may provide a foundation for teams working to implement systems improving 
transition of care from obstetric to primary care. QI projects with integration in the EMR could be an 
ideal model for quickly testing strategies to increase communication between providers and also 
patients and providers about current access to primary care. 
This study has notable limitations. First, its data source in the EMR relies on billing data and diagnostic 
codes which may not be reflective of accurate type of visit. For example, it is possible preventive 
screenings were done at a PCP visit that did not have an associated preventive billing code. In addition, 
generalizing utilization of the general singleton population should be cautioned as it is possible patients 
received care out of network or transferred care during the course of the study. It is also important to 
note that UVMMC is the primary academic institution in Vermont and therefore the obstetric 
population may be at higher risk than the rest of the state. As mentioned above, this study is currently 
limited in its analysis as it is bivariate and a multivariate analysis is still pending.  
Conclusion 
In summary, we have reported the healthcare visit patterns in the LPP of women who had a singleton 
pregnancy with a particular focus on primary and preventive care use in the LPP. Prevalence of PCP visits 
in the LPP is high among patients with an established PCP (75.0%) but much lower preventive PCP LPP 
visits (29.9%). Associations with increased preventive PCP LPP visits included including having the same 
delivering provider as PCP (OR 1.742), a pre-pregnancy PCP visit (OR 1.460), a PCP visit during prenatal 
time (OR 1.459, documented ED EPP visit (OR 0.402), a fetal or neonatal demise (OR 0.445), being single 
(0.601), and with public health insurance (OR 0.489). Further work in understanding these associations 
will be important in developing improved transition of care models and increasing overall engagement 
in women’s preventive medicine.  
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